Fig. 4: Ingenuity pathway analysis reveals key pathways altered due to LIMK2 inhibition. | Oncogenesis

Fig. 4: Ingenuity pathway analysis reveals key pathways altered due to LIMK2 inhibition.

From: LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1

Fig. 4

a LIMK2 phosphorylation site consensus sequence identified by dagLogo package. b Top 10 signaling pathways identified using IPA analysis on SILAC data. c Overlap of signaling network regulated by LIMK2 identified by IPA software. d Schematic diagram illustrating the SRPK1-regulated signaling network.

Back to article page